Cart
sales@molnova.com
Eldacimibe
CAS No. 141993-70-6
Eldacimibe( —— )
Catalog No. M34583 CAS No. 141993-70-6
Eldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 333 | In Stock |
|
| 10MG | 504 | In Stock |
|
| 25MG | 816 | In Stock |
|
| 50MG | 1097 | In Stock |
|
| 100MG | 1479 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2967 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEldacimibe
-
NoteResearch use only, not for human use.
-
Brief DescriptionEldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia.
-
DescriptionEldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorAcyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number141993-70-6
-
Formula Weight634.89
-
Molecular FormulaC39H58N2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N(CC1=CC=C(CC(C)(C)C)C=C1)CCCCCC)(NC2=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C2)=C3C(=O)OC(C)(C)OC3=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ophiopogonanone C
Ophiopogonanone C is a homoisoflavonoidal compound isolated as a constitutent from the tuber of Ophiopogon japonicas.
-
RS 0481
RS 0481 modulates the immune response and rebuilds lymphocyte populations damaged by tumor growth in animals.
-
ProTx III
Potent Nav1.7 blocker (IC50 = 2.5 nM). Also inhibits Nav1.1, Nav1.2, Nav1.3 and Nav1.6 in the nanomolar range. Exhibits no effects on Cav channels or nAChR at 5 μM. Demonstrates analgesic activity in vivo; antagonizes effects of scorpion-venom toxin OD1 at Nav1.7.
